Introduction
============

Redox midpoint potential (*E*~m~) is a key property of any redox active cofactor in proteins. It regulates biological functions via thermodynamic and kinetic control of electron exchange reactions. Because these reactions must take place in a variety of cellular compartments, both outside and inside the biological membrane, the structures of redox proteins have evolved to meet physicochemical requirements of these various environments to achieve assemblies that secure functionally competent *E*~m~ values.

Within the group of cytochromes, molecular factors that modulate *E*~m~ include types of heme axial ligation ([@B1][@B2][@B3]). The residues that are most commonly recruited as axial ligands for the heme iron are His and/or Met ([@B4]). A binding of hemes *b* within the membranous proteins is accomplished by an assembly of transmembrane α-helices that provide His axial ligands for the heme-iron. In fact, the heme binding α-helix bundle represents a common motif of several bioenergetic complexes ([@B5][@B6][@B7]). It has even been used as a prototype to construct human-made versions of heme binding proteins (protein maquettes) ([@B8][@B9][@B10]).

The α-helix bundle can bind one or two hemes *b*. In several proteins, an assembly of two *b* type hemes, each facing different sides of the membrane, supports electron transfer across biological membranes crucial for energy conservation in many systems. Intriguingly, the two hemes differ largely in their redox midpoint potentials (the *E*~m~ difference, Δ*E*~m\_~b, is typically in the range of 100 mV); however, the thermodynamic rationale behind the existence of Δ*E*~m\_~b remains unclear. This is because no general rule for the direction of Δ*E*~m\_~b with respect to the direction of the electric field generated by the membrane potential or the direction of physiological electron transfer is evident ([Fig. 1](#F1){ref-type="fig"}).

![**Possible thermodynamic configurations for cross-membrane electron transfer in cytochromes *b*.** *a*, electron is transferred against ΔΨ and involves energetically favorable reduction of heme *b*~H~ by heme *b*~L~. *b*, electron is transferred against ΔΨ and additionally involves energetically unfavorable reduction of heme *b*~L~ by heme *b*~H~. *c*, energetically unfavorable reduction of heme *b*~L~ by heme *b*~H~ is facilitated by ΔΨ. *d*, energetically favorable reduction of heme *b*~H~ by heme *b*~L~ is additionally facilitated by ΔΨ. *b*~L~ and *b*~H~ denote low potential and high potential heme, respectively. The *blue arrow* refers to ΔΨ (membrane electric potential); the *purple arrow* indicates the direction of ΔΨ-induced electron transfer; and the *green arrows* indicate direction of electron transfer between hemes. Configuration *a* can be found in cytochrome *bc*~1~ ([@B11], [@B12]), cytochrome *b*~6~*f* ([@B37]), nitrate reductase A (*NarA*) ([@B39], [@B40]), and fumarate reductase (*QFR*) ([@B41], [@B42]); configuration *b* can be found in formate dehydrogenase N (*FdN*) ([@B40], [@B43]) and perhaps in membrane-bound \[Ni-Fe\] hydrogenase (*MBH*) ([@B45], [@B46]); configuration *c* can be found in succinate dehydrogenase (*SQR*) ([@B47], [@B48]), cytochromes *b*~561~ (*b561*) ([@B52][@B53][@B54]), and NADPH oxidase (*NOX*) ([@B51]); and configuration *d* probably exists in thiosulfate reductase (*Phs*) ([@B55]).](zbc0161640770001){#F1}

The cytochrome *b* subunit of cytochrome *bc*~1~ (mitochondrial complex III) is a well known example of a protein supporting cross-membrane electron transfer by using an assembly of two hemes *b*, named heme *b*~H~ and heme *b*~L~, where subscripts H and L refer to high and low potential, respectively (for recent reviews see Refs. [@B11] and [@B12]). During the catalytic cycle, the electron transfer from heme *b*~L~ to heme *b*~H~ connects the quinol oxidation site (Q~o~)[^2^](#FN2){ref-type="fn"} and the quinone reduction site (Q~i~). In addition, in dimeric structure of an enzyme, intermonomer electron transfer parallel to the membrane plane involving two hemes *b*~L~ is possible ([@B13][@B14][@B16]). In living cells, the cross-membrane electron flow from heme *b*~L~ to heme *b*~H~ may face the barrier of the membrane potential ([Fig. 1](#F1){ref-type="fig"}*a*). Thus, the fact that electrons are transferred from the cofactor of lower *E*~m~ to the cofactor of higher *E*~m~ provided a basis for a general assumption that Δ*E*~m\_~b is one of the factors that facilitate cross-membrane electron transfer and perhaps is important in overcoming the barrier of potential ([@B17], [@B18]). However, the contribution of Δ*E*~m\_~b to the overall electron flow has not been verified experimentally. Prerequisites for such verification are variants of cytochrome *bc*~1~ with large changes in the *E*~m~ of hemes *b* and, consequently, large changes in Δ*E*~m\_~b. However, the mutations of cytochrome *b* tested so far either had a relatively small effect on the *E*~m~ of hemes *b* ([@B19], [@B20]) or resulted in the absence of the heme ([@B21], [@B22]).

Here we mutated the native bis-His coordination pattern for heme *b*~L~ and/or heme *b*~H~ into the His-Lys pattern, to our knowledge, providing the first His-Lys coordinated hemes *b* in a transmembrane protein. The hemes remain low spin as in a native enzyme but have markedly elevated *E*~m~ values and thus effectively modulate Δ*E*~m\_~b: an increase in the *E*~m~ of heme *b*~H~ by 50 mV increased Δ*E*~m\_~b setting the *E*~m~ of heme *b*~H~ above the *E*~m~ of the quinone pool in the membrane, whereas an increase in the *E*~m~ of heme *b*~L~ by 155 mV decreased Δ*E*~m\_~b to the point that the two hemes *b* were almost isopotential. This provided an unprecedented set of large changes in Δ*E*~m\_~b for functional testing. The results offer a new perspective toward understanding the natural engineering of the cross-membrane electron transfer in cytochromes *b*.

Experimental Procedures
=======================

### 

#### Bacterial Strains, Plasmids, and Growth Conditions

*Rhodobacter capsulatus* and *Escherichia coli* (HB101, DH5α) were grown in liquid or solid MPYE (mineral-peptone-yeast extract) and LB (Luria Bertani) media, at 30 and 37 °C, respectively, supplemented with appropriate antibiotics as needed. Respiratory growth of *R. capsulatus* strains was achieved at 30 °C in the dark under semiaerobic conditions. Photosynthetic growth abilities of mutants were tested on MPYE plates using anaerobic jars (GasPak^TM^ EZ Anaerobe Container System; BD Biosciences) at 30 °C under continuous light. The *R. capsulatus* strains used were: pMTS1/MTR*bc*~1~ which overproduces wild-type cytochrome *bc*~1~ from the expression vector pMTS1 (contains a copy of pet*ABC* operon coding for all three subunits of cytochrome *bc*~1~), and MTR*bc*~1~ which is a pet*ABC* operon deletion background ([@B23]). The mutagenized pMTS1 derivatives were introduced to *R. capsulatus* MTR*bc*~1~ via triparental crosses as described ([@B23]). Plasmid pPET1 (a derivative of pBR322 containing a wild-type copy of pet*ABC*) was used as a template for PCR and in some of the subcloning procedures.

#### Construction of Lys Mutants

Spontaneous Ps^+^ revertant of the H212N mutant originally described in Ref. [@B22] was obtained on MPYE plate containing tetracycline after ∼7 days of cultivation under photosynthetic conditions. The DNA sequence analysis of the plasmid DNA isolated from the revertant strain revealed a single base pair change replacing the mutated Asn into Lys at position 212 of cytochrome *b*. The XmaI/SfuI fragment containing the reversion (mutation H212K), and no other mutations was exchanged with its counterpart on expression vector pMTS1 carrying the wild-type copy of the pet*ABC* operon. Expression of this vector in the MTR*bc*~1~ background strain confirmed that cells bearing single mutation H212K display the photosynthetically competent Ps^+^ phenotype. The Ps^+^ reversion H212K occurred also in the double mutant A181T/H212N cultivated on MPYE plate containing kanamycin (in this case H212N in the cytochrome *b* subunit was accompanied by a mutation A181T in cytochrome *c*~1~ described originally in Ref. ([@B24])). Because A181T/H212N, unlike original H212N, contained cytochrome *b* already equipped with the Strep-tag II attached to its carboxyl end, the plasmid obtained from the revertant of A181T/H212N was used to construct the mutants used in further analysis. First, the XmaI/SfuI fragment containing the reversion (H212K) and the sequence coding for Strep-tag II (ST), and no other mutations were exchanged with its counterpart on expression vector pMTS1 carrying the wild-type copy of the pet*ABC* operon. This created pMTS1-ST-H212K. Second, the same XmaI/SfuI fragment was cloned into pPET1 creating pPET1-ST-H212K. Mutation H198K and the double mutation H212K/H198K were constructed by the QuikChange site-directed mutagenesis kit from Stratagene using pPET1-ST ([@B25]) and pPET1-ST-H212K plasmids as templates, respectively, and the mutagenic forward H198K-F (5′-GGGCAGCAGATATTTCAGCGAGAAGAAGCGG-3′) and reverse H198K-R (5′-TTCTTCTCGCTGAAATATCTGCTGCCCTTCG-3′) oligonucleotides. After sequencing, XmaI/SfuI fragments of pPET1 plasmids bearing the desired mutations, and no other mutations were exchanged with their wild-type counterparts in pMTS1. This created the plasmids pMTS1-ST-H198K and pMTS1-ST-H212K/H198K. Plasmids pMTS1-ST-H212K, pMTS1-ST-H198K, and pMTS1-ST-H212K/H198K were inserted into *R. capsulatus* MTRBC1 cells, creating mutants H212K, H198K, and H212K/H198K, respectively. These mutants are listed in [Table 1](#T1){ref-type="table"}. In each case, the presence of introduced mutations was confirmed by sequencing the plasmid DNA reisolated from the mutated *R. capsulatus* strains.

#### Isolation of Membranes and Proteins

Chromatophore membranes were isolated from *R. capsulatus* as described previously ([@B26]). The cytochrome *bc*~1~ complexes were isolated from detergent-solubilized chromatophores by affinity chromatography using the procedure described previously ([@B27]). SDS-PAGE of purified complexes was performed as described before ([@B28]).

#### Optical and EPR Spectroscopy

Optical spectra measurements of isolated complexes and determination of protein concentration were performed on UV-2450 Shimadzu spectrophotometer. Cytochrome *bc*~1~ samples were suspended in 50 m[m]{.smallcaps} Tris, pH 8.0, 100 m[m]{.smallcaps} NaCl, 0.01% (m/m) dodecyl maltoside, and 1 m[m]{.smallcaps} EDTA, an appropriate amount of ferricyanide was added to fully oxidize complexes; then solid ascorbate and solid sodium dithionite were added to reduce samples, and spectra were recorded right after oxidation and after each step of reduction. Concentration of cytochrome *bc*~1~ was determined as described ([@B26]). EPR measurements were performed on Bruker Elexys E580 spectrometer. X-band CW-EPR spectra of hemes were measured at 10 K, using SHQE0511 resonator combined with ESR900 Oxford Instruments cryostat unit, using 1.595 mT modulation amplitude, and 1.543 milliwatt of microwave power. For EPR measurements, cytochrome *bc*~1~ samples were dialyzed against 50 m[m]{.smallcaps} Tris, pH 8.0, 100 m[m]{.smallcaps} NaCl, 20% glycerol (v/v), 0.01% (m/m) dodecyl maltoside, and 1 m[m]{.smallcaps} EDTA. Final concentration of cytochrome *bc*~1~ in EPR samples was 50 μ[m]{.smallcaps}. Antimycin A was used in 5-fold molar excess over the concentration of cytochrome *bc*~1~.

#### Redox Potentiometry

Midpoint potentials of hemes *b* were determined by dark equilibrium redox titrations on chromatophores according to the method described in Ref. ([@B29]). Chromatophores were suspended in argon-equilibrated 50 m[m]{.smallcaps} MOPS buffer (pH 7.0) containing 100 m[m]{.smallcaps} KCl and 1 m[m]{.smallcaps} EDTA. Immediately before the titration, the following redox mediators were added: 100 μ[m]{.smallcaps} tetrachlorohydroquinone, 100 μ[m]{.smallcaps} 2,3,5,6-tetramethyl phenylenediamine (*E*~m7~ 260 mV), 100 μ[m]{.smallcaps} 1,2-naphtoquinone-4-sulfonate (*E*~m7~ 210 mV), 100 μ[m]{.smallcaps} 1,2-naphtoquinone (*E*~m7~ 130 mV), 50 μ[m]{.smallcaps} phenazine methosulfate (*E*~m7~ 80 mV), 50 μ[m]{.smallcaps} phenazine ethosulfate (*E*~m7~ 50 mV), 100 μ[m]{.smallcaps} duroquinone (*E*~m7~ 5mV), 30 μ[m]{.smallcaps} indigotrisulfonate (*E*~m7~ = −90 mV), 100 μ[m]{.smallcaps} 2-hydroxy-1,4-napthoquinone (*E*~m7~ = −152 mV), 100 μ[m]{.smallcaps} anthroquinone-2-sulfonate (*E*~m7~ = −225 mV), and 100 μ[m]{.smallcaps} benzyl viologen (*E*~m7~ = −374 mV). Dithionite and ferricyanide were used to adjust ambient redox potential. During the titrations, samples of 150--200 μl were taken and transferred to EPR tubes anaerobically and frozen by immersion into cold ethanol. The *E*~m7~ values of hemes *b* were determined by fitting the amplitudes of appropriate EPR *g*~z~ transitions to the Nernst equation for one-electron couple (for WT, H212K, and H198K) or for two one-electron couples (in case of H212K/H198K mutant).

#### Flash-induced Electron Transfer Measurements

Measurements of flash-induced turnover kinetics of cytochrome *bc*~1~ were performed on a home-built double wavelength time-resolved spectrophotometer as described in previous work ([@B24]). Chromatophores for measurements were suspended in 50 m[m]{.smallcaps} MOPS, pH 7.0, 100 m[m]{.smallcaps} KCl, 3.5 μ[m]{.smallcaps} valinomycin, and redox mediators: 7 μ[m]{.smallcaps} 2,3,5,6-tetramethyl-1,4-phenylenediamine, 1 μ[m]{.smallcaps} phenazine methosulfate, 1 μ[m]{.smallcaps} phenazine ethosulfate, 5.5 μ[m]{.smallcaps} 1,2-naphthoquinone, and 5.5 μ[m]{.smallcaps} 2-hydroxy-1,4-naphthoquinone (valinomycin and redox mediators were added immediately before the measurement). Dithionite and ferricyanide were used to adjust ambient redox potential. Inhibitors antimycin A and myxothiazol were used at final concentration of 7 μ[m]{.smallcaps}. Transient hemes *b* reduction kinetics were followed at 560--570 nm (for WT and H198K) or 557--570 nm (for H212K and H212K/H198K). Transient hemes *c* oxidation and rereduction kinetics were followed at 550--540 nm. Single flash activation measurements were initiated by a short saturating flash (10 μs) from a xenon lamp, and multiple flash activation measurements were initiated by a series of short (10 μs) saturating flashes every 20 ms. In order to measure kinetics in the presence of the membrane potential, valinomycin was omitted. Rates of flash-induced heme *b* reduction were determined by fitting transient kinetics data to a single exponential equation.

#### Steady-state Kinetics Measurements

Steady-state enzymatic activities of cytochrome *bc*~1~ complexes in chromatophores were determined spectroscopically by the decylubiquinol-dependent reduction of bovine heart cytochrome *c* (Sigma-Aldrich) as described before ([@B23]). Conditions used in assays were as follows: 50 m[m]{.smallcaps} Tris-HCl (pH 8), 100 m[m]{.smallcaps} NaCl, 20 μ[m]{.smallcaps} decylubiquinol, 20 μ[m]{.smallcaps} oxidized cytochrome *c*. Errors were calculated as standard deviation of the mean of nine measurements. Chromatophores were treated with KCN (final concentration in sample was 0.5 m[m]{.smallcaps}) before experiments. Decylubiquinol was obtained as described ([@B30]).

Results
=======

### 

#### His-Lys Ligation for Hemes b in a Low Spin State Is Possible in Transmembrane Cytochrome b

Changes in the coordination pattern of heme iron are expected to exert a large influence on the redox properties of hemes ([@B1]). Thus, to impose large shifts in *E*~m~ values of hemes *b* in cytochrome *b*, we created three variants in which one of the His ligands to heme iron was replaced by Lys (Lys mutants): single mutants H212K (for heme *b*~H~) and H198K (for heme *b*~L~) and the double mutant H212K/H198K combining both single mutations ([Fig. 2](#F2){ref-type="fig"}*a*).

![**His-Lys coordinated hemes *b* contain low spin heme iron and have markedly increased *E*~m~.** *a*, schematic representation of four-helix bundles (*tubes*) binding two hemes *b* (*brown diamonds*) and introduced changes in the ligation pattern; *H* and *K* denote His and Lys ligands of heme iron, respectively. The respective *E*~m~ diagrams are shown *below* the schemes. *Black bars* refer to *E*~m7~ of hemes, the *blue line* indicates *E*~m7~ of Q pool, *orange lines* indicate calculated *E*~m7~s of Q~i~/SQ~i~ and SQ~i~/Q~i~ couples (*upper* and *lower line*, respectively), and the *red line* indicates the resulting average *E*~m7~ of Q at the Q~i~ catalytic site. *b*, EPR spectra of hemes *b* in isolated complexes in the absence of inhibitors and presence of antimycin (*black* and *gray*, respectively). The *numbers* above the spectra and *dotted lines* denote values and positions of *g*~z~ transitions.](zbc0161640770002){#F2}

The mutated complexes contained all three catalytic subunits, as indicated by the SDS electrophoretic profiles ([Fig. 3](#F3){ref-type="fig"}*a*). Optical (UV-visible), and electron paramagnetic resonance spectroscopy (EPR) showed that the mutants contained all redox active cofactors: heme *c*~1~, hemes *b* (*b*~L~ and *b*~H~) and 2Fe-2S cluster ([Figs. 2](#F2){ref-type="fig"}*b* and [3](#F3){ref-type="fig"}, *b* and *c*). Although the spectral and redox properties of 2Fe-2S and heme *c*~1~ remained unchanged in the mutants, the properties of hemes *b* were modified. We emphasize the results of EPR analysis ([Fig. 2](#F2){ref-type="fig"}*b*), which in this case is most informative because, unlike UV-visible spectroscopy, it allows for a complete spectral separation of *g* transitions originating from each of the hemes *b*: in native enzyme *g* = 3.78 and 3.44, corresponding to *g*~z~ transition of heme *b*~L~ and heme *b*~H~, respectively ([@B31]).

![**SDS-PAGE profiles, spectral analyses, and growth capability of Lys mutants of cytochrome *bc*~1~.** *a*, Coomassie Blue-stained SDS-PAGE profiles of complexes isolated from solubilized membranes. *b*, optical absorption spectra of isolated complexes: *dashed lines*, ascorbate-reduced samples; *solid lines*, dithionite-reduced samples. *c*, X-band CW-EPR spectra of reduced 2Fe-2S clusters present in samples of isolated complexes. Spectra were recorded at 20 K, 1.7 mT modulation amplitude, and 2.015 milliwatts of microwave power. *d*, photosynthetic growth under anaerobic conditions at pH 7. MTR*bc*~1~ (*R. capsulatus* strain lacking cytochrome *bc*~1~ operon) was used as negative control. *e*, heterotrophic growth in aerobic dark conditions (cytochrome *bc*~1~-independent) at pH 7 was used as positive control.](zbc0161640770003){#F3}

The mutationally imposed changes in ligation pattern resulted in the disappearance of the *g*~z~ transition of the targeted heme at the position characteristic for a native enzyme with concomitant appearance of new transitions at *g* = 3.22 and 3.15 ([Fig. 2](#F2){ref-type="fig"}*b*, *black*). More specifically, these new transitions replaced *g* = 3.78 in H198K, *g* = 3.44 in H212K, and both *g* = 3.78 and 3.44 in the double mutant H212K/H198K. In general, these shifts reflect a lowering of the symmetry and changes from a highly axial to a more rhombic low spin heme ([@B32]). The new transitions *g* = 3.22 and 3.15 are assigned to *g*~z~ transitions of low spin hemes *b* coordinated by His-Lys. Support for this assignment comes from the differential effect of antimycin, an inhibitor that binds to the Q~i~ site in the proximity of heme *b*~H~, and is known to affect the EPR spectrum of heme *b*~H~ ([@B33]). Antimycin clearly affects the *g* = 3.22 and 3.15 of heme *b*~H~ in H212K and H212K/H198K, whereas in H198K it has a weak or no effect ([Fig. 2](#F2){ref-type="fig"}*b*, *gray*). In H212K/H198K, for which both hemes *b*~L~ and *b*~H~ contribute to 3.22 and 3.15 transitions, the effect of antimycin is intermediary between the largest and smallest effect seen in H212K and H198K, respectively.

#### His-Lys Coordinated Hemes b Have Markedly Elevated E~m~, Effectively Modulating ΔE~m\_~b

Dark equilibrium redox titrations revealed that changing the ligation pattern from bis-His to His-Lys in hemes *b* leads to a significant increase in their *E*~m~ values. This increase reaches 50 mV for heme *b*~H~ in H212K and almost 160 mV for heme *b*~L~ in H198K ([Fig. 4](#F4){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). At the same time, there was no significant change of *E*~m~ (only ∼10 mV increase was observed in *E*~m~ for heme *b*~L~ in H212K or 20 mV decrease of *E*~m~ for heme *b*~H~ in H198K) in the heme that was not subject to modification in these mutants. A large increase in the *E*~m~ of just one heme (*b*~L~ or *b*~H~) effectively modulated Δ*E*~m\_~b in those mutants ([Fig. 2](#F2){ref-type="fig"}*a*). In H212K Δ*E*~m\_~b was increased, and *E*~m~ of heme *b*~H~ rose above the *E*~m~ of quinone pool in the membrane ([@B34], [@B35]). In H198K Δ*E*~m\_~b was decreased to the point that both hemes became almost isopotential. In H212K/H198K, both His-Lys ligated hemes showed *E*~m~ of ∼72 mV. This means that only heme *b*~L~ elevated its *E*~m~. Consequently, the Δ*E*~m\_~b in this mutant is similar to that of H198K.

![**Midpoint potentials of hemes *b* determined via EPR-monitored redox titrations.** Each *blue line* represents the Nernst titration curve. The respective *E*~m~ values are given in the middle of each plot. Titrations were performed on isolated chromatophores at pH 7.0. Amplitudes of heme *b*~L~ and heme *b*~H~ were monitored at respective *g* values: 3.78 and 3.44 in WT, 3.22 and 3.44 in H198K, 3.78 and 3.2 in H212K, and 3.2 in H212K/H198K.](zbc0161640770004){#F4}

###### 

**Selected properties of wild-type and Lys mutants**

  Form of *bc*~1~   Phenotype   *E*~m7~   EPR *g*~z~ value   Rates of hemes *b* reduction   Steady-state activity                               
  ----------------- ----------- --------- ------------------ ------------------------------ ----------------------- ----------- ------ -------- ---------
                                *mV*                                                        *s*^−*1*^               *s*^−*1*^                   
  WT                Ps^+^       −92       80                 3.78                           3.44 (3.47)             566         1051   1791     149 ± 7
  H212K             Ps^+^       −86       130                3.78                           3.22/3.15 (3.26)        479         822             121 ± 6
  H198K             Ps^+^       65        58                 3.22                           3.44 (3.47)             392         770    1506     118 ± 5
  H212K/H198K       Ps^+^       ∼72       ∼3.2               ∼3.2 (∼3.24)                   420                     706         1548   91 ± 6   

#### Mutants with Large Changes in ΔE~m\_~b Are Functional in Vitro and in Vivo

Remarkably, all mutants showed the capability to grow under cytochrome *bc*~1~-dependent photoheterotrophic conditions (*i.e.* exhibited the Ps^+^ phenotype), which indicated that mutated cytochromes *bc*~1~ are functional *in vivo* ([Table 1](#T1){ref-type="table"} and [Fig. 3](#F3){ref-type="fig"}, *d* and *e*). The functional competence of these mutants was confirmed by light-induced electron transfer measurements that allow monitoring of individual reactions associated with the catalytic cycle. In brief, these reactions include oxidation of quinol at the Q~o~ site, which delivers one electron to one cofactor chain (the c chain) consisting of a 2Fe-2S cluster, heme *c*~1~ and heme *c*~2~. The other electron is used to reduce heme *b*~L~ in a separate chain (the b chain), followed by cross-membrane electron transfer to heme *b*~H~, which then reduces the occupant of the Q~i~ site.

The kinetic transients shown in [Fig. 5](#F5){ref-type="fig"} monitored changes in the oxidation state of heme *b*~H~ associated with electron transfer through the b chain. When the quinone (Q) pool is poised half-reduced before light activation (ambient potential of 100 mV at pH 7) ([Fig. 5](#F5){ref-type="fig"}*a*), cytochrome *bc*~1~ in native chromatophores and in the absence of any inhibitors displays a fast reduction of heme *b*~H~ followed by its fast reoxidation (WT, *black trace*). The reduction phase is mediated by an electron from the Q~o~ site, whereas the reoxidation phase results from electron transfer to the occupant of the Q~i~ site. In the presence of antimycin, the reoxidation phase is blocked, and heme *b*~H~ remains reduced within the time domain monitored in the experiment (WT, *red trace*). The rate of this reduction (measured at pH 7), as well as the rates measured at two other pH values (pH 6 and 9, which test conditions of different driving force provided by substrates) are listed in [Table 1](#T1){ref-type="table"}. All phases of the electron transfer described above and involving heme *b*~H~ (in the absence of any inhibitors and in the presence of antimycin) are observed in all Lys mutants, and the measured rates of heme *b*~H~ reduction at pH 6, 7, or 9 are only slightly lower than the corresponding rates in wild type ([Fig. 5](#F5){ref-type="fig"}*a* and [Table 1](#T1){ref-type="table"}). This reveals a full competence of catalytic reactions of Q~o~ and Q~i~ sites in the mutants. We note the smaller amplitude of heme *b*~H~ reduction in the presence of antimycin in H212K mutant. This is an effect of a partial prereduction of this heme before activation, which is a consequence of an elevated *E*~m~ exceeding the *E*~m~ of the Q pool.

![**Single flash-activated transients reveal fast heme *b* reduction and changes in equilibria of partial reactions in Lys mutants.** *a*, transients in the absence of inhibitor (*black*) after addition of antimycin (*red*) and subsequent addition of myxothiazol (*blue*) recorded at pH 7 and ambient potential of 100 mV (Q pool half-reduced). *b*, same as in *a*, except that ambient potential was 200 mV (Q pool oxidized). *c*, same as in *b*, except that the order of addition of inhibitors was inverted: antimycin (*red*) was subsequent to myxothiazol (*blue*). Transient hemes *b* reduction kinetics for WT and H198K were followed at 560--570 nm and for H212K and H212K/H198K at 557--570 nm.](zbc0161640770005){#F5}

Kinetic competence of the mutants was also evident in the response of cytochrome *bc*~1~ to multiple flash activation in both the absence and presence of membrane potential. In the absence of inhibitors, hemes *c* in native enzyme and H198K undergo several cycles of fast oxidation and rereduction ([Fig. 6](#F6){ref-type="fig"}*a*, *black*), and hemes *b* undergo several cycles of fast reduction and reoxidation ([Fig. 6](#F6){ref-type="fig"}*b*, *black*). As expected, antimycin impedes the rereduction phase of hemes *c* ([Fig. 6](#F6){ref-type="fig"}*a*, *red*) and blocks the reoxidation phase of hemes *b* ([Fig. 6](#F6){ref-type="fig"}*b*, *red*). The membrane potential diminishes the effectiveness of the rereduction of hemes *c* and reoxidation of hemes *b*, leading to partial accumulation of oxidized hemes *c* and reduced hemes *b*, but the magnitude of this effect in native enzyme and H198K is similar. In multiple flash experiments, H212K behaved similarly to H198K.

![**Multiple flash-activated competence of enzyme with isopotential hemes *b* in the absence and presence of electric membrane potential.** *a*, transients for hemes *c* oxidation and rereduction in WT and H198K activated by 10 flashes separated by 20 ms in the absence of inhibitors (*black*) and in the presence of antimycin (*red*), in the absence (ΔΨ = 0) or presence (ΔΨ ≠ 0) of the membrane potential, recorded at pH 7 and ambient potential of 100 mV. *b*, transients for hemes *b* recorded as in *a*.](zbc0161640770006){#F6}

Enzymatic competence of the Lys mutants is evident in the measured steady-state turnover rates, which remain in good correlation with the results of light-induced electron transfer measurements. As listed in [Table 1](#T1){ref-type="table"}, the turnover rates in H212K or H198K single mutants and in H212K/H198K double mutant decrease by 20 and 40%, respectively, compared with WT. Clearly, all Lys mutants retain significant enzymatic activity.

#### Changes in ΔE~m\_~b Affect Equilibria of Partial Reactions

Kinetic traces measured when the Q pool is fully oxidized before activation (ambient potential of 200 mV at pH 7) are compared in [Fig. 5](#F5){ref-type="fig"}*b*. Under these conditions, the amount of quinol molecules after activation is limited, and consequently, approximately only one quinol is oxidized in every Q~o~ site. It follows that a difference between the level of reduction of heme *b*~H~ in the absence and presence of antimycin reports equilibration of electron between heme *b*~H~^3+^/*b*~H~^2+^ and quinone/semiquinone (Q/SQ) couples at the Q~i~ site. In native enzyme and H198K mutant, this difference is large, indicating that the electron resides mostly on semiquinone at the Q~i~ site (∼80%). However, in H212K mutant, the amplitude of reduced heme *b*~H~ in the absence of inhibitors is significantly larger than in wild type. This indicates that equilibrium between heme *b*~H~^3+^/*b*~H~^2+^ and Q/SQ is shifted so that the electron resides mostly on heme *b*~H~ (at the expense of semiquinone). This shift is a consequence of an elevated *E*~m~ of heme *b*~H~ in H212K, which exceeds the *E*~m~ of Q/SQ at pH 7 ([Fig. 2](#F2){ref-type="fig"}*a*).

Another way to monitor electron equilibration between heme *b*~H~ and the occupant of the Q~i~ site benefits from the occurrence of reverse reaction in the Q~i~ site ([Fig. 5](#F5){ref-type="fig"}*c*). When the Q pool is fully oxidized before light activation, and the Q~o~ site is blocked by an inhibitor (myxothiazol), light-induced reduction of heme *b*~H~ reports electron transfer from quinol that entered the Q~i~ site to heme *b*~H~. However, in a native enzyme, this reaction cannot be observed at pH 7 ([Fig. 5](#F5){ref-type="fig"}*c*, *blue*), which seems consistent with the fact that *E*~m~ of heme *b*~H~ is lower than *E*~m~ of the Q pool. On the other hand, at this pH, the reverse electron transfer from Q~i~ site quinol to heme *b*~H~ is prominent in H212K ([Fig. 5](#F5){ref-type="fig"}*c*, *blue*). Furthermore, the amplitude of heme *b*~H~ reduction in this reaction (*i.e.* in the presence of myxothiazol) is almost as large as the amplitude of heme *b*~H~ reduction in the absence of any inhibitor.

Equilibration of electrons between heme *b*~H~ and the occupant of the Q~i~ site in H212K mutant under the conditions described in [Fig. 5](#F5){ref-type="fig"} (*b* and *c*) allowed us to estimate the *E*~m~ values for the SQ/QH~2~ and Q/SQ redox couples at the Q~i~ site at pH 7. The extent of forward reaction (electron transfer from heme *b*~H~ to Q) monitored in [Fig. 5](#F5){ref-type="fig"}*b* will reflect the difference between the *E*~m~ of heme *b*~H~^3+^/*b*~H~^2+^ and the *E*~m~ of Q/SQ couples, whereas the extent of the reverse reaction (electron transfer from quinol to heme *b*~H~) monitored in [Fig. 5](#F5){ref-type="fig"}*c* will reflect the difference between the *E*~m~ of heme *b*~H~^3+^/*b*~H~^2+^ and the *E*~m~ of SQ/QH~2~ couples. Based on these assumptions, and considering *E*~m7~ = 130 mV for heme *b*~H~ in an H212K mutant, we estimate values of *E*~m7~ for the Q/SQ couple to be ∼114 mV, and *E*~m7~ for the SQ/QH~2~ couple to be 147 mV. The average redox midpoint potential for Q/QH~2~ (*E*~m7~ for Q/QH~2~) is then 130 mV, which makes it isopotential with the *b*~H~^3+^/*b*~H~^2+^ couple in an H212K mutant and ∼30 mV higher than the *E*~m~ of Q in the Q pool reported in the literature. The split in quinone redox couples defines the stability constant for SQ ([@B35], [@B36]); thus, our estimates of *E*~m7~ for Q/SQ and *E*~m7~ for SQ/QH~2~ indicate the stability constant (log(*K*~s~) = \[*E*~m(Q/SQ)~ − *E*~m(SQ/QH2)~\]/60) for SQ~i~ at the level of 3 × 10^−1^.

Discussion
==========

We have examined the effect of large changes in ΔG on electron transfer between hemes *b* in cytochrome *bc*~1~. These changes were implemented by significant increases in the *E*~m~ values of the hemes, which came as a result of mutating the native bis-His coordination of the heme iron into the His-Lys coordination. Our results indicate that the natural difference in *E*~m~ values of the two hemes *b* (Δ*E*~m\_~b) of 170 mV can be increased to 210 mV (in H212K) or diminished to almost 0 (in H198K and double mutant H212K/H198K), and the complex still remains functional *in vivo*, retaining the catalytically relevant electron transfer from the Q~o~ to Q~i~ sites measured *in vitro* under the absence or presence of membrane potential. The electron flow through cofactor chains of cytochrome *bc*~1~ in all those mutants proceeded from the primary electron donor (QH~2~ in the Q~o~ site) to the final electron acceptor (Q or SQ in the Q~i~ site) at physiologically and mechanistically competent rates, although changes in Δ*E*~m\_~b affected equilibrium levels of partial reactions in the coupled electron transfer chains. Clearly, these changes did not introduce any significant barrier to electron transfer from donor to final acceptor. It thus appears that cytochrome *bc*~1~ can accommodate large changes in Δ*E*~m\_~b without hampering catalysis, as long as these changes do not impose overly endergonic steps on the route of electron transfer from substrate to product. The previously reported moderate decrease in *E*~m~ for heme *b*~H~ in yeast cytochrome *bc*~1~ falls into this category of changes, *i.e.* ones not imposing overly endergonic steps, and thus, consistent with our observations, did not affect significantly the measured turnover rate of the enzyme ([@B20]).

Considering the direction of electron flow and the direction of the gradient of *E*~m~ in relation to the vector of the electric membrane potential, four configurations are possible ([Fig. 1](#F1){ref-type="fig"}). In cytochrome *bc*~1~ ([@B11], [@B12]), cytochrome *b*~6~*f* ([@B37], [@B38]), nitrate reductase A ([@B39], [@B40]), and quinol-fumarate reductase ([@B41], [@B42]), the high potential heme *b* is located at the negative side of the membrane ([Fig. 1](#F1){ref-type="fig"}*a*), which at first would seem to be in line with the concept of the obligatory difference in *E*~m~ to overcome membrane potential. However, in formate dehydrogenase N ([@B40], [@B43], [@B44]) and probably in membrane-bound \[Ni-Fe\] hydrogenase ([@B45], [@B46]), the low potential heme is located at the negative side of the membrane, and the electron is transferred against both the electric membrane and the redox potential of hemes *b* ([Fig. 1](#F1){ref-type="fig"}*b*), which remains at odds with the concept presented above. The third possibility found in succinate-quinone reductase ([@B47][@B48][@B50]), NADPH oxidase ([@B51]), or cytochrome b~561~ family ([@B52][@B53][@B54]) is simply an inversion of the case in [Fig. 1](#F1){ref-type="fig"}*a* with electron transfer from high to low potential facilitated by the presence of electric membrane potential ([Fig. 1](#F1){ref-type="fig"}*c*). The fourth possibility ([Fig. 1](#F1){ref-type="fig"}*d*) perhaps concerns proton motive force-driven electron transfer in thiosulfate reductase, if heme *b*~L~ in this enzyme is located close to the menaquinone binding site, as in formate dehydrogenase N (which seems likely, based on sequence similarities between the cytochrome *b* subunits of these complexes) ([@B55]).

The occurrence of all these configurations suggests that there is no a universal rule for the arrangement of *E*~m~ values of hemes *b* among various transmembrane cytochromes *b*. This, however, becomes understandable in light of our observation that large Δ*E*~m\_~b and fine tuning of *E*~m~ values of hemes *b* of cytochrome *bc*~1~ are not required for efficient cross-membrane electron transfer. Another example of tolerance for changes in Δ*E*~m\_~b for cross-membrane electron transfer concerns *Bacillus subtilis* succinate-quinone reductase. In this case, the mutant with the His-Met ligated heme *b*~L~ having the *E*~m~ increased by at least 100 mV is expected to diminish the barrier for the uphill step of electron transfer from heme *b*~H~ to heme *b*~L~ ([Fig. 1](#F1){ref-type="fig"}*c*) but, at the same time, to introduce a barrier for electron transfer from heme *b*~L~ to menaquinone. However, such modification, despite lowered enzymatic activity, did not eliminate the function of the enzyme *in vivo*. Furthermore, its activity to reduce ubiquinone was not significantly affected ([@B48]).

Extrapolating all these observations to other cytochromes *b*, it can be proposed that, in all those proteins, hemes *b* simply act as electronic connectors for the catalytic sites with no fine tuning in Δ*E*~m\_~b required for efficient electron transfer. It follows that the existence of Δ*E*~m\_~b in transmembrane embedded hemes *b* is not an element in the control of electron flow across the membrane. Rather, it may be a consequence of a higher probability of coexistence of two cofactors having different *E*~m~ in comparison to the case when the two cofactors have similar *E*~m~. Intriguingly, we found one resemblance for enzymes with one quinone binding site: from two hemes *b* of different potentials, the one with the lower potential is adjacent to the quinone binding site ([Fig. 7](#F7){ref-type="fig"}) ([@B38], [@B39], [@B42], [@B44][@B45][@B47], [@B49], [@B50]). Further studies are required to verify whether this has any functional relevance or is just a consequence of structural constraints. Nevertheless, this resemblance may be useful in predicting the location of low and high potential heme *b* in quinol-binding cytochromes, for which such assignments are yet to be made.

![**Localization of low and high potential hemes *b* with respect to the quinone binding site in cytochrome *b* subunits of enzymes involved in cross-membrane electron transfer.** *a*, in cytochromes *b* with one Q binding site, low potential heme (*b*~L~) is adjacent to the Q binding site, whereas high potential heme (*b*~H~) faces the opposite side of the membrane. *b*, in cytochromes *bc*, the cytochrome *b* subunit contains two Q binding sites and heme *b*~L~ is adjacent to one site (Q~o~), whereas heme *b*~H~ is adjacent to the other (Q~i~). *Brown diamonds*, hemes *b*; *yellow hexagons*, Q binding sites. *Numbers* indicate *E*~m~ values (in mV) for pH 7. *Superscripts A*, *B*, and *C* refer to *E*~m~ values for pH 7.6, 7.2, and 7.5, respectively. Types of natively used quinones are given below the *E*~m~ values. Localization of hemes in membrane-bound \[Ni-Fe\] hydrogenase (*MBH*) is presumable; thus, its name is given in italic. Protein names abbreviations as in [Fig. 1](#F1){ref-type="fig"}. Other abbreviations as follow: *B. c., Bacillus cereus; B. s., Bacillus subtilis; C. j., Campylobacter jejuni; C. r., Chlamydomonas reinhardtii; E. c., Escherichia coli; H. p., Helicobacter pylori; R. e., Ralstonia eutropha; R. c., Rhodobacter capsulatus; T. a., Thermoplasma acidophilum; W. s., Wolinella succinogenes;* MK, menaquinone; TPQ, thermoplasmaquinone; PQ, plastoquinone; UQ, ubiquinone.](zbc0161640770007){#F7}

The demonstrated robustness of cytochrome *b* to changes in ligation pattern and associated changes in Δ*E*~m\_~b raises an interesting question as to whether variation in the heme ligation patterns exists in natural membrane proteins of similar design and/or function. Such variation is evident in the group of cytochromes *c* for which bis-His ([@B4], [@B56], [@B57]), His-Met ([@B4], [@B56], [@B57]), His-Lys ([@B58]), His-Cys ([@B59][@B60][@B61]), or even His-Tyr ([@B62], [@B63]) patterns ligating heme iron are observed. However, in most known cytochromes *c*, the heme binding domains are water-soluble or solvent-exposed (so far, the heme *c*~x~ from cytochrome *b*~6~ is the only known exception ([@B5], [@B64], [@B65])), whereas in cytochromes *b* these domains can be located either in membrane or in aqueous phase ([@B5]). It may seem that the location of the heme binding motifs outside the membrane environment is one of the factors increasing structural flexibility to accommodate diverse heme ligation. Indeed, all rare cases of His-Met ([@B66], [@B67]), Lys-Met ([@B68]), or bis-Met ([@B69], [@B70]) ligations in cytochromes *b* are relevant only to water-soluble domains. In fact, to our knowledge, no cases have been reported so far of Met or Lys serving naturally as axial ligands for hemes bound within the integral membrane proteins.

However, our Lys mutants prove that His-Lys ligation for hemes *b* can occur within the transmembrane helix bundle of cytochrome *b*, yielding functional hemes that contain a low spin form of iron ion. Notably, the H212K mutant was originally isolated as a reversion for H212N, the so-called heme *b*~H~ knock-out, with impaired electron transfer at the level of the heme *b*~H~/Q~i~ site. Likewise, the His-Met heme *b* mutant of *B. subtilis* succinate-quinone reductase was isolated as a reversion of nonfunctional Leu mutant ([@B48]). This all indicates that an assembly of functionally active low spin heme *b* present within the transmembrane segment of the protein and coordinated by His and Lys or Met is feasible from a protein engineering perspective. If this is the case, one should expect that there are natural cases of His-Lys and His-Met ligation patterns for membranous heme proteins ([@B71]) that still await identification, especially because the range of scrutinized heme proteins is currently continuously widening.
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